These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16112700)
1. Characterization of a novel protein from Proatheris superciliaris venom: proatherocytin, a 34-kDa platelet receptor PAR1 agonist. Laing GD; Compton SJ; Ramachandran R; Fuller GL; Wilkinson MC; Wagstaff SC; Watson SP; Kamiguti AS; Theakston RD; Senis YA Toxicon; 2005 Oct; 46(5):490-9. PubMed ID: 16112700 [TBL] [Abstract][Full Text] [Related]
2. Functional roles of the two distinct domains of halysase, a snake venom metalloprotease, to inhibit human platelet aggregation. You WK; Jang YJ; Chung KH; Jeon OH; Kim DS Biochem Biophys Res Commun; 2006 Jan; 339(3):964-70. PubMed ID: 16329990 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function. McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Lee CY; Teng CM Thromb Haemost; 2002 Jun; 87(6):1026-33. PubMed ID: 12083482 [TBL] [Abstract][Full Text] [Related]
5. A novel 25 kDa protein from the venom of Bitis arietans with similarity to C-type lectins causes fibrinogen-dependent platelet agglutination. Jennings B; Spearman W; Shephard E Toxicon; 2005 Nov; 46(6):687-98. PubMed ID: 16168448 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827 [TBL] [Abstract][Full Text] [Related]
7. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML; Hamm HE J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299 [TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and expression of a functional snake venom serine proteinase, with platelet aggregating activity, from the Cerastes cerastes viper. Dekhil H; Wisner A; Marrakchi N; El Ayeb M; Bon C; Karoui H Biochemistry; 2003 Sep; 42(36):10609-18. PubMed ID: 12962484 [TBL] [Abstract][Full Text] [Related]
9. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom. Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053 [TBL] [Abstract][Full Text] [Related]
10. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Day JR; Haskard DO; Taylor KM; Landis RC Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862 [TBL] [Abstract][Full Text] [Related]
11. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Vretenbrant K; Ramström S; Bjerke M; Lindahl TL Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509 [TBL] [Abstract][Full Text] [Related]
12. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase. Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047 [TBL] [Abstract][Full Text] [Related]
13. Characterization and molecular cloning of dabocetin, a potent antiplatelet C-type lectin-like protein from Daboia russellii siamensis venom. Zhong SR; Jin Y; Wu JB; Chen RQ; Jia YH; Wang WY; Xiong YL; Zhang Y Toxicon; 2006 Jan; 47(1):104-12. PubMed ID: 16330060 [TBL] [Abstract][Full Text] [Related]
14. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. Andrews RK; Gardiner EE; Asazuma N; Berlanga O; Tulasne D; Nieswandt B; Smith AI; Berndt MC; Watson SP J Biol Chem; 2001 Jul; 276(30):28092-7. PubMed ID: 11344165 [TBL] [Abstract][Full Text] [Related]
15. Amyloid beta peptide-activated signal pathways in human platelets. Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Wu CC; Teng CM Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Huang KF; Ko TP; Hung CC; Chu J; Wang AH; Chiou SH Biochem J; 2004 Mar; 378(Pt 2):399-407. PubMed ID: 14613481 [TBL] [Abstract][Full Text] [Related]
18. Isolation of bothrasperin, a disintegrin with potent platelet aggregation inhibitory activity, from the venom of the snake Bothrops asper. Pinto A; Angulo Y; Jiménez R; Lomonte B Rev Biol Trop; 2003 Mar; 51(1):253-9. PubMed ID: 15162701 [TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro. Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]